Announcements Trials

Browse Landscape

Status

Withdrawn 1 Recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Breast 10 Gastrointestinal 6 Thoracic 4 Lymphoid 3 Other 2 Plasma cell 1 Other hematologic neoplasm 1 Gynecologic 1 Genitourinary 1 Dermatologic 1 Classical hematology 1 CNS 1

Conditions

Melanoma 390 Skin Neoplasms 90 Carcinoma, Non-Small-Cell Lung 79 Breast Neoplasms 56 Neoplasms 55 Colorectal Neoplasms 53 Lung Neoplasms 52 Neoplasm Metastasis 46 Ovarian Neoplasms 44 Lymphoma, T-Cell, Cutaneous 44 Carcinoma, Renal Cell 43 Squamous Cell Carcinoma of Head and Neck 42 Uveal Melanoma 39 Pancreatic Neoplasms 38 Sarcoma 36 Carcinoma, Basal Cell 36 Head and Neck Neoplasms 33 Uterine Cervical Neoplasms 32 Prostatic Neoplasms 32 Stomach Neoplasms 31 Carcinoma, Merkel Cell 30 Carcinoma, Hepatocellular 30 Endometrial Neoplasms 29 Urinary Bladder Neoplasms 28 Kidney Neoplasms 26 Triple Negative Breast Neoplasms 24 Esophageal Neoplasms 22 Carcinoma, Squamous Cell 22 Lymphoma 20 Mycosis Fungoides 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Inflammation × Dermatologic × Clear all

NCT07138222 2026-01-28

IMPACT

Peter MacCallum Cancer Centre, Australia

Inflammation, Melanoma, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡